
Vir Biotechnology
Data breach claim reported November 17, 2026
| Data Breach Report | |||
|---|---|---|---|
| Victim | vir.bio | ||
| Claimed By | n0n | ||
| Date Discovered | Nov 17, 2026 | ||
| Description | Vir Biotechnology, Inc. is a clinical-stage biotechnology company based in USA (California), developing therapies for chronic hepatitis B and hepatitis delta and for cancer. | ||
| Leak Size | Unknown |
Breach claims on this page are published by threat actors and haven't been verified by Breachsense.
Credential Exposure for vir.bio
We've indexed 11 @vir.bio accounts from external breaches, plus 2 credentials for vir.bio itself.
Last checked Nov 17, 2026
| @vir.bio addresses from external breaches | |
|---|---|
| Third-party breaches | 6 accounts · across 6 breaches · 3 with a plaintext password · most recent Aug 18, 2024 |
| Combo lists | 6 accounts · most recent Nov 15, 2026 |
| Passwords for vir.bio accounts | |
|---|---|
| Combo lists | 2 logins · most recent Nov 15, 2026 |
Logins may belong to customers or to staff, and the data doesn't say which. None of this is necessarily connected to the ransomware attack above.
Is your organization next?
Check if your company's credentials have been exposed in this or other data breaches.
Continuous dark web monitoring alerts you when we find leaked credentials or session tokens for your company.